You searched for "underactive"
Recent developments in bladder cancer – MIBC
This article takes a look back over recent years at new innovations and developments relating to muscle-invasive bladder cancer (MIBC) specifically, and will also touch upon what the future may hold. This article is also written as a continuation of...
An Illustrated Guide to Pediatric Urology
This new illustrated guide (published 2017) provides a comprehensive coverage of the field of paediatric urology. There are 31 chapters. Written in bullet point form, it contains a wealth of information for urologists, specialty trainees and others (e.g. urological nurses)....USANZ Trainee Week 2022 – a trip down under
The BAUS Section of Trainees (BSoT) opened applications for two senior UK urology trainees to be sponsored to attend the annual Urological Society of Australia and New Zealand (USANZ) Trainee Week, in Melbourne. The week is held in November each...
Which is better – laparoscopic or open paediatric pyeloplasty?
In an attempt to answer the above question, Gatti et al. undertook a randomised controlled trial between 2005 and 2014. All children aged 1 to 18 years of age requiring surgery for pelviureteric junction (PUJ) obstruction were enrolled. A total...
Durability and complications of photoselective vaporisation of the prostate with GreenLightTM
Alternatives to the standard transurethral resection of the prostate (TURP) in the management of bladder outflow obstruction due to prostatic hypertrophy are becoming more common. In this retrospective case series, the outcomes of 117 patients undergoing GreenLightTM lithium triborate photoselective...The Lester Eshleman Urology Workshop (Tanzania): a trainee’s perspective
For many trainees a period abroad is increasingly an essential supplement to higher surgical training in the UK. However, for many, because of family responsibilities or financial imperatives, this is not always a viable option. There are however alternatives. Here...Neuroendocrine bladder tumour
A 75-year-old male with a history of prostate adenocarcinoma (T3b/T4 N1 M1b, Gleason 4+3) on Zoladex® and enzalutamide, presented with visible haematuria. His prostate specific antigen (PSA) had decreased from 43.6ug/L in December 2022 to 0.02ug/L. He also had a...
